In November 1950, a freak storm spawned a record storm surge in Atlantic City and a near-record surge at Sandy Hook. Rutgers scientists are studying weather systems known as extratropical cyclones or nontropical storms, and the storm surges they have generated along the northern East Coast.
The Alzheimer’s Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna® for use as a cancer therapy) in patients with Alzheimer’s disease.
Rutgers Cancer Institute of New Jersey researchers in the Precision Medicine Program aim to validate a new genomic sequencing approach that may help identify a sub-set of triple-negative breast cancers. The work is supported by a grant from the Val Skinner Foundation.
A database study examining surgical removal of the prostate gland (radical prostatectomy) or a form of radiation therapy known as IMRT to treat prostate cancer that has spread to other parts of the body (metastatic) shows an association between each of these treatments and improved overall survival.
Intern Mark Thom, an engineering graduate student at Howard University, helped get a robotic arm on the Princeton Plasma Physics Laboratory operational during a summer internship at PPPL.
In the wake of the recent terror events, a Rutgers expert discusses how to discuss violence-related fears with young children and warning signs to anticipate.
Shantenu Jha is a RADICAL man. Jha and his RADICAL (Rutgers Advanced Distributed Cyberinfrastructure and Applications Laboratory) team operate at the crossroads of computing and science, and their work has benefited research in the molecular sciences, polar sciences and high-energy physics.
Researchers from Columbia University, Rutgers University, and other institutions have identified genomic alterations in pediatric relapsed ALL that cause both therapy resistance and improved clinical response to multi-agent chemotherapy treatment.
K. Hovnanian Children’s Hospital at Jersey Shore University Medical Center was selected as a charitable partner of Spirit Halloween’s Spirit of Children program, which provides fun and funding to its partner hospitals during the Halloween season and all year long. As part of the Spirit of Children program, 11 Spirit Halloween stores in the local area will conduct in-store fundraising campaigns that will specifically benefit the Child Life Program at K. Hovnanian Children’s Hospital. In addition to collecting in-store donations, when customers utilize Spirit Halloween’s 10-for-10 coupon, they receive 10% off their purchase and Spirit Halloween will match it with a 10% donation.
A new partnership between Rutgers Cancer Institute of New Jersey and University Hospital in Newark is resulting in the expansion of National Cancer Institute (NCI)-designated Comprehensive Cancer Center services to northern New Jersey.
Two new companies from Rutgers presented Sept. 20 at University Startup Demo Day in the U.S. Capitol Building. Celvive is refining a stem-cell technology for regenerative medicine use such as spinal cord injury. XPEED Turbine Technology is developing aerodynamic technology for wind energy production.
Research from Rutgers Cancer Institute of New Jersey and other U.S. health and academic institutions shows a diet high in calcium and low in lactose may reduce the risk of ovarian cancer in African-American women. The work also found sun exposure in the summer months may reduce the risk of developing the disease in this population.
Undergraduate women in physics and other STEM fields are encouraged to apply for the 2017 Conference for Undergraduate Women in Physics (CUWiP) Mid-Atlantic regional conference Jan. 13 to 15 at Princeton University. The conference will focus on workshops aimed at providing tools to encourage women to remain in science, technology, engineering, and mathematics (STEM) fields. The application deadline is Oct. 14.
A clinical trial underway – known as the AMP study (for Antibody Meditated Prevention) – will determine whether infusing an experimental antibody (VRC01) into HIV-negative men and transgender individuals who have sex with men, will prevent the acquisition of HIV.
A new study published in the Journal of The Electrochemical Society (JES) is taking a fundamental step forward in advancing Li-air through the development of mixed metal catalyst that could lead to more efficient electrode reactions in the battery.
PRiME is the largest, most significant research conference of its kind in the world. Learn more about presentations to be delivered by pioneering researchers in renewable energy, biomedical, sensors, and more.
SR Instruments, a leading manufacturer of purpose-built scales for hospitals, medical facilities, and long term centers, today announced that its flagship product line, SR Scales, has been selected as the preferred provider of portable wheelchair scales for all Life Care Centers of America institutions. With over 200 locations nationwide, Life Care Centers provide unparalleled medical and rehabilitative care for their residents.
Bayshore Community Hospital Foundation will host the first annual Benefit for Bayshore Oktoberfest Celebration on Friday, October 7, 2016 from 6:30 p.m. to 10:30 p.m. and invites all members of the community to register to attend. The tented cocktail reception will uniquely take place on the hospital’s campus at 727 North Beers Street in Holmdel and will support Bayshore’s plans to enhance emergency services.
Medicinal chemist and pharmacologist Daniel Martin Watterson, PhD, has been named the second annual winner of the Alzheimer’s Drug Discovery Foundation’s (ADDF) Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery. The prize is the first to specifically recognize researchers working in promising areas of drug discovery for Alzheimer’s disease and related dementias. Dr. Watterson is the John G. Searle Professor of Molecular Biology and Biochemistry and Professor of Pharmacology at Northwestern University’s Feinberg School of Medicine. He also serves in an advisory role to pharmaceutical and biotechnology companies.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 19th Annual European Congress that will be held 29 October–2 November 2016 in Vienna, Austria.
Hanna Schamis was inspired to pursue a graduate degree in plasma physics by her summer internship at the U.S. Department of Energy's Princeton Plasma Physics Laboratory (PPPL). In her graduate work at the University of Illinois at Urbana-Champaign, she plans to continue research she did this summer at PPPL. Schamis studied the effect of plasma on materials that could be used in fusion devices to protect them from the intense heat of plasmas, which can reach temperatures of up to 100 million degrees. She did the research on a device called the Material Analysis and Particle Probe (MAPP). The device is attached to the National Spherical Torus Experiment-Upgrade. MAPP allows scientists to expose materials to a plasma during an experiment and analyze them in a vacuum chamber that is part of the device.
Physicists at the U.S. Department of Energy's (DOE) Princeton Plasma Physics Laboratory (PPPL) have successfully tested a new device that will lead to a better understanding of the interactions between ultrahot plasma contained within fusion facilities and the materials inside those facilities.
Tuberculosis persists in many patients after they receive drug therapies, while others relapse after being successfully cured of symptoms, according to a study published in Nature Medicine. The findings highlight the importance of immune systems in eradicating the disease, and provide markers to test new treatments.
The third plenary session for ISPOR’s 7th Asia-Pacific Conference—The Affordable Dream in ASEAN: Experiences and Lessons Learned—was held this morning in Singapore.
The second plenary session for the the ISPOR 7th Asia-Pacific Conference—Harnessing the Power of Big Data to Make Better Health Care Decisions in the Asia-Pacific Region—was held this morning in Singapore.
ISPORis first plenary session for the Society’s 7th Asia-Pacific Conference—Health Technology Assessment and Health Policy: Recent Developments Across Asia—was held this afternoon in Suntec City, Singapore.
Princeton Plasma Physics Laboratory (PPPL) summer Max Wallace was once a programmer who worked for Silicon Valley. Wallace used his talents to develop a software tool that gives scientists a snapshot of plasma experiments on PPPL's National Spherical Torus Experiment-Upgrade (NSTX-U).
Rutgers University engineers have found a simple method for producing high-quality graphene that can be used in next-generation electronic and energy devices: bake the compound in a microwave oven. The discovery is documented in a study published online today in the journal Science.
"Taking Chances: The Coast After Hurricane Sandy" investigates whether Sandy was “a transformational event, just another storm or something in between.” Topics include the meteorology and climatology of Sandy, efforts to “Restore the Shore,” and impacts on water, wastewater and electrical utilities.
Jersey Shore University Medical Center announces that it has earned The Joint Commission’s Gold Seal of Approval® for Advanced Certification in Inpatient Diabetes Care. The Gold Seal of Approval® is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care.
ISPOR's Medical Devices and Diagnostics Special Interest Group report, “Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations,” was published in the July/August 2016 issue (Volume 19, Issue 5) of Value in Health.
ISPOR announced today the publication of a series of articles suggesting that the application of cost-effectiveness analysis for health care decision making in the US may be approaching critical mass. This special themed section was published in the July/August 2016 in Value in Health.
Dr. Jennifer Caudle, a family physician, medical correspondent and assistant professor at Rowan University School of Osteopathic Medicine has been tapped to be one of seven 2017 Miss America Competition Preliminary Judges.
Rutgers researchers discovered that mTOR responds to decreasing levels of nutrients, acting as “traffic control” to help stabilize cells as nutrient intake fluctuates. The study is the first to indicate that mTOR actively participates in the process to restore cell stability when there are not enough nutrients to fuel cell growth.
Each year, the pilgrimage for new school supplies is a given as the summer draws to a close. But one thing you should be sure to include on your back-to-school checklist is a call to the pediatrician to ensure your child’s vaccinations are up to date, Rutgers pediatric specialists say.
Thanks to a two-year, $70,000 commitment from Embrace Kids Foundation, the Comprehensive Sickle Cell Center housed at Rutgers Cancer Institute of New Jersey is expanding to include a Pediatric Sickle Cell and Hemoglobinopathies Nurse Navigator position.
ISPOR announced confirmation of key scientific sessions for its 7th Asia-Pacific Conference scheduled to begin next week, 3-6 September 2016 in Singapore.
Riverview Medical Center, a member of the Hackensack Meridian Health family, was named as an Affiliate Treatment Center by the National Lymphedema Network. An Affiliated Treatment Center is a center in which more than one therapist is a certified lymphedema therapist, and is properly trained to successfully treat and manage Lymphedema affecting various parts of the body.
Research from investigators at Rutgers Cancer Institute of New Jersey; University of California, Los Angeles; University of California, Santa Cruz and other institutions shows a computational approach examining abnormal “signaling” in clinical prostate cancer tissues that is responsible for their spread and resistance to treatment and can help identify patient subsets for targeted therapies.